Mechanism of Diabetes

NEW Product Launch: Diabetes & Obesity Peptides!

Published on 30/01/2025

We are currently expanding our types of peptides, and this week, we are happy to introduce a new product line to our peptide catalogDiabetes & Obesity Peptides. 

Our unique Diabetes & Obesity peptide catalog comes with a list of benefits: 

  • >95% purity (determined via LCMS)
  • Quantification via amino acid analysis (AAA) allowing for high reliability in dose-dependent studies
  • Common impurities for Liraglutide and Glucagon in addition to classic diabetes peptides 
  • Applications: from basic research to analytical studies 


Current Research with Diabetes & Obesity Peptides 

With diabetes being among the leading causes of death, finding treatments for both type 1 (insulin dependent), and type 2 (insulin resistant) diabetes is imperative. In particular, type 2 diabetes research is showing potential with peptide-based treatments, focusing on glucagon-like peptide 1 (GLP-1) receptor agonists, (e.g. GLP-1, GIP, semaglutide, or liraglutide), which have been shown to affect insulin release, decrease glucagon secretion and reduce gastric emptying. In addition, diagnostic markers such as C-peptide are also useful in tracking the disease. 


Take a Look at our Diabetes & Obesity Peptides

  •  Amylin 
  • C-Peptide 
  • Exendin-4 
  • Gastric Inhibitory Polypeptide (GIP) – GLP1 receptor agonist 
  • Ghrelin 
  • Glucagon 
  • Glucagon-like Peptides 1 (GLP1) 
  • Liraglutide - GLP1 receptor agonist 
  • Oxyntomodulin (OXM) 
  • Pancreatic Polypeptide 
  • Pramlintide - Amylin Analog Semaglutide – GLP1 receptor agonist 

Take another look at our other peptides in our catalog


Custom Peptides according to Your Needs:

If you are unable to find a suitable peptide in our catalog or require further features and modifications, we excel in our custom peptide synthesis services

  • Customizable solutions: Our peptides are customized for your research needs, whether studying C-peptide for Type 1 diabetes, developing therapies for Type 2 diabetes, exploring GLP-1 receptor agonists, or analyzing diabetes peptide impurities. 
  • Expert support team to optimize the use of peptides to your unique research requirements. 
  • Cost-Effective & Scalable: Ranging from µ-grams to grams, suitable for both small-scale studies and large-scale screenings.
  • Purity grades: We typically make our diabetes & obesity peptides available at a purity of >95%, but will also offer our peptides at lower purity if necessary 
  • Modifications possible: lipidation, pegylation, non-natural AAs, heavy isotope labeling, and many more 


For bulk orders or custom peptide inquiries, please contact us to discuss your specific needs. Explore the potential of diabetes peptides in diverse applications, from gene editing and RNA interference studies to targeted drug delivery and cancer research. 

Send us quote request or discuss your research projects with our experienced team.

Check our list of products, click and go.

Get a quote